医学
肝病学
乙型肝炎病毒
慢性肝炎
临床试验
乙型肝炎
肝病
临床实习
疾病
重症监护医学
临床疗效
临床研究
内科学
免疫学
病毒
家庭医学
出处
期刊:PubMed
日期:2023-04-20
卷期号:31 (4): 389-400
被引量:1
标识
DOI:10.3760/cma.j.cn501113-20230314-00113
摘要
Hepatitis B virus biomarkers are mainly used in clinical practice to diagnose infection, monitor disease progression, evaluate response to chronic hepatitis B treatment, and evaluate the efficacy of novel antiviral drugs in clinical trials. In combination with the recent research progress of antiviral therapy for chronic hepatitis B and the actual needs of clinical diagnosis and treatment, the expert consensus was formulated by the Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association. It summarized the evidence and recommended the key points for the clinical application of classic and novel hepatitis B virus related biomarkers in order to guide the standardized and reasonable clinical application for these biomarkers.临床实践中,乙型肝炎病毒标志物主要用于诊断感染、监测疾病进展、评估慢性乙型肝炎治疗应答,以及在临床试验中评估新型抗病毒药物的疗效。结合近年来慢性乙型肝炎抗病毒治疗的研究进展和临床诊治实际需求,中华医学会肝病学分会基础医学与实验诊断协作组制订此专家共识,对经典及新型乙型肝炎病毒实验室检测相关标志物的临床应用进行证据总结和要点推荐,旨在指导其规范、合理的临床应用。.
科研通智能强力驱动
Strongly Powered by AbleSci AI